ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+4.22%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$290M
AUM Growth
+$290M
(-23%)
Cap. Flow
-$73M
Cap. Flow
% of AUM
-25.2%
Top 10 Holdings %
Top 10 Hldgs %
69.2%
Holding
34
New
2
Increased
3
Reduced
20
Closed
3
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$7.18M |
| 2 |
AXDX
Accelerate Diagnostics
AXDX
|
$2.43M |
| 3 |
Sarepta Therapeutics
SRPT
|
$1.31M |
| 4 |
Fortress Biotech
FBIO
|
$174K |
| 5 |
Iovance Biotherapeutics
IOVA
|
$51.7K |
Top Sells
| 1 |
Acadia Pharmaceuticals
ACAD
|
$19.2M |
| 2 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$9.94M |
| 3 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$8.75M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$8.04M |
| 5 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$7.87M |
Sector Composition
| 1 | Healthcare | 90.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $39.8M | 13.69% | 1,258,055 -195,000 | -13% | -$6.16M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $34.1M | 11.75% | 3,515,611 -734,588 | -17% | -$7.13M |
|
|
3
Iovance Biotherapeutics
IOVA
$807M
| $24.6M | 8.48% | 3,187,607 +6,694 | +0.2% | +$51.7K |
|
|
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $21.2M | 7.29% | 784,199 -20,100 | -2% | -$543K |
|
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $19.4M | 6.68% | 503,007 +33,982 | +7% | +$1.31M |
|
|
PTX
6
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $15.2M | 5.23% | 5,144,916 -859,648 | -14% | -$2.54M |
|
|
DERM
7
DELISTED
Dermira, Inc.
DERM
| $12.3M | 4.23% | 354,950 -8,300 | -2% | -$287K |
|
|
TLGT
8
DELISTED
Teligent, Inc
TLGT
| $12.2M | 4.21% | 1,373,294 -406,488 | -23% | -$3.62M |
|
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $11.7M | 4.04% | 1,260,809 -863,784 | -41% | -$8.04M |
|
|
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $9.99M | 3.44% | 1,146,579 -1,004,858 | -47% | -$8.75M |
|
|
AGEN
11
Agenus
AGEN
$133M
| $9.98M | 3.44% | 2,199,137 | – | – |
|
|
CASC
12
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $9.14M | 3.15% | 4,119,072 -1,387,546 | -25% | -$3.08M |
|
|
NDRM
13
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $8.87M | 3.05% | 520,022 -583,071 | -53% | -$9.94M |
|
14
ImmunityBio
IBRX
$2.21B
| $8.83M | 3.04% | 599,287 -129,600 | -18% | -$1.91M |
|
|
AEGR
15
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $7.41M | 2.55% | 733,125 -73,175 | -9% | -$739K |
|
|
16
Neurocrine Biosciences
NBIX
$13.8B
| $7.18M | 2.47% | +127,000 | New | +$7.18M |
|
|
SIOX
17
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.54M | 1.91% | 307,070 -99,400 | -24% | -$1.79M |
|
18
Veracyte
VCYT
$2.39B
| $5.34M | 1.84% | 741,353 -30,944 | -4% | -$223K |
|
|
EGLT
19
DELISTED
Egalet Corporation
EGLT
| $4.77M | 1.64% | 432,606 -8,000 | -2% | -$88.2K |
|
|
INNL
20
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $4.16M | 1.43% | 501,722 -700 | -0.1% | -$5.81K |
|
|
21
Fortress Biotech
FBIO
$76.8M
| $3.73M | 1.29% | 1,337,869 +62,348 | +5% | +$174K |
|
|
TRIL
22
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.2M | 1.1% | 253,697 -1,400 | -0.5% | -$17.7K |
|
23
Vericel Corp
VCEL
$1.83B
| $2.93M | 1.01% | 1,135,120 | – | – |
|
24
Tonix Pharmaceuticals
TNXP
$260M
| $2.61M | 0.9% | 340,300 -70,000 | -17% | -$537K |
|
|
AXDX
25
DELISTED
Accelerate Diagnostics
AXDX
| $2.43M | 0.84% | +112,885 | New | +$2.43M |
|